It has been shown that anti-endothelial antibodies such as anti-CD31 and anti-D34 are commonly used to assess angiogenesis, but these endothelial antibodies respond not only with emerging vessels, but also with normal vessels in tumor tissue (17). The gene discussed is PECAM1; the disease is neoplasm.